跳至主要内容

Biphasic Insulin Aspart 30 Therapy in Insulin-Naïve and Insulin-Experienced Patients with Type 2 Diabetes: Results from the Jordanian Subgroup of the A1chieve Study

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51841#.VHfSm2fHRK0

Objective: To analyse the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in a Jordanian subgroup of the 24-week, non-interventional A1chieve study. Methods: A total of 509 Jordanian patients with type 2 diabetes (392 insulin-naive and 117 insulin-experienced) starting BIAsp30, alone or in combination with oral glucose-lowering drugs, were included. Safety and effectiveness outcomes were analysed over 24 weeks. Results: Patients had a mean age of 55.8 years, body mass index of 28.8 kg/m2 and diabetes duration of 9.4 years at baseline. Two serious adverse drug reactions of hypoglycaemia were reported. The proportion of patients who reported major hypoglycaemic events decreased (2.4% at baseline vs. 0.2% at Week 24, p = 0.0039). The proportion of patients reporting overall hypoglycaemia increased marginally (6.3% at baseline vs. 9.9% at Week 24, p = 0.0378), primarily attributed to a rise in minor and nocturnal hypoglycaemia reported in insulin-naive patients. From baseline to Week 24, the mean ± SD glycated haemoglobin A1c level decreased from 9.8% ± 1.4% to 7.4% ± 0.9% (p < 0.001). Significant reductions after 24 weeks were also noted in the mean fasting plasma glucose, postprandial plasma glucose, lipids, systolic blood pressure and quality of life (all p < 0.001), while the mean body weight increased by 1.8 ± 6.5 kg (p < 0.001). Conclusion: Overall, BIAsp 30 therapy was well-tolerated and resulted in improved glycaemic control in this Jordanian subgroup over 24 weeks.
Cite this paper
Haddad, J. , Haddad, F. , Nasser, R. , Al-Shudifat, A. , Annabi, F. , Sandalci, L. and Al-Kilani, M. (2014) Biphasic Insulin Aspart 30 Therapy in Insulin-Naïve and Insulin-Experienced Patients with Type 2 Diabetes: Results from the Jordanian Subgroup of the A1chieve Study. Journal of Diabetes Mellitus, 4, 379-387. doi: 10.4236/jdm.2014.44051.
 

[1] Rawal, L.B., Tapp, R.J., Williams, E.D., Chan, C., Yasin, S. and Oldenburg, B. (2012) Prevention of Type 2 Diabetes and Its Complications in Developing Countries: A Review. International Journal of Behavioral Medicine, 19, 121-133. http://dx.doi.org/10.1007/s12529-011-9162-9
[2] International Diabetes Federation (2011) International Diabetes Federation (IDF) Diabetes Atlas. 5th Edition, IDF, Brussels.
[3] Zindah, M., Belbeisi, A., Walke, H. and Mokdad, A.H. (2008) Obesity and Diabetes in Jordan: Findings from the Behavioral Risk Factors Surveillance System, 2004. Preventing Chronic Disease, 5, A17.
[4] Khattab, M., Khader, Y.S., Al-Khawaldeh, A. and Ajlouni, K. (2010) Factors Associated with Poor Glycemic Control among Patients with Type 2 Diabetes. Journal of Diabetes and Its Complications, 24, 84-89. http://dx.doi.org/10.1016/j.jdiacomp.2008.12.008
[5] Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., et al. (2012) Management of Hyperglycaemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia, 55, 1577-1596. http://dx.doi.org/10.1007/s00125-012-2534-0
[6] Brunton, S. (2009) Safety and Effectiveness of Modern Insulin Therapy: The Value of Insulin Analogs. Consultant, 49, S13-S19.
[7] Halimi, S., Raskin, P., Liebl, A., Kawamori, R., Fulcher, G. and Yan, G. (2005) Efficacy of Biphasic Insulin Aspart in Patients with Type 2 Diabetes. Clinical Therapeutics, 27, S57-S74.
http://dx.doi.org/10.1016/j.clinthera.2005.11.021
[8] Davidson, J., Vexiau, P., Cucinotta, D., Vaz, J. and Kawamori, R. (2005) Biphasic Insulin Aspart 30: Literature Review of Adverse Events Associated with Treatment. Clinical Therapeutics, 27, S75-S88. http://dx.doi.org/10.1016/j.clinthera.2005.11.022
[9] Davidson, J.A., Liebl, A., Christiansen, J.S., Fulcher, G., Ligthelm, R.J., Brown, P., et al. (2009) Risk for Nocturnal Hypoglycemia with Biphasic Insulin Aspart 30 Compared with Biphasic Human Insulin 30 in Adults with Type 2 Diabetes Mellitus: A Meta-Analysis. Clinical Therapeutics, 31, 1641-1651.
http://dx.doi.org/10.1016/j.clinthera.2009.08.011
[10] Liebl, A., Prusty, V., Valensi, P., Kawamori, R., Christiansen, J.S., Palmer, A.J., Balschmidt, P., Ligthelm, R. and Mohan, V. (2012) Ten Years of Experience with Biphasic Insulin Aspart 30: From Drug Development to the Latest Clinical Findings. Drugs, 72, 1495-1520.
http://dx.doi.org/10.2165/11635490-000000000-00000
[11] Home, P., Naggar, N.E., Khamseh, M., Gonzalez-Galvez, G., Shen, C., Chakkarwar, P., et al. (2011) An Observational Non-Interventional Study of Patients with Diabetes Beginning or Changed to Insulin Analogue Therapy in Non-Western Countries: The A1chieve Study. Diabetes Research and Clinical Practice, 94, 352-363. http://dx.doi.org/10.1016/j.diabres.2011.10.021
[12] Stratton, I.M., Adler, A.I., Neil, H.A., Matthews, D.R., Manley, S.E., Cull, C.A., et al. (2000) Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes (UKPDS 35): Prospective Observational Study. British Medical Journal, 321, 405-412.
http://dx.doi.org/10.1136/bmj.321.7258.405
[13] Abdel-Aal, N.M., Ahmad, A.T., Froelicher, E.S., Batieha, A.M., Hamza, M.M. and Ajlouni, K.M. (2008) Prevalence of Dyslipidemia in Patients with Type 2 Diabetes in Jordan. Saudi Medical Journal, 29, 1423-1428.
[14] Braun, A., Samann, A., Kubiak, T., Zieschang, T., Kloos, C., Müller, U.A., et al. (2008) Effects of Metabolic Control, Patient Education and Initiation of Insulin Therapy on the Quality of Life of Patients with Type 2 Diabetes Mellitus. Patient Counselling and Health Education, 73, 50-59.
http://dx.doi.org/10.1016/j.pec.2008.05.005                eww141128lx
标签：

评论

发表评论

此博客中的热门博文

A Comparison of Methods Used to Determine the Oleic/Linoleic Acid Ratio in Cultivated Peanut (Arachis hypogaea L.)

Cultivated peanut ( Arachis hypogaea L.) is an important oil and food crop. It is also a cheap source of protein, a good source of essential vitamins and minerals, and a component of many food products. The fatty acid composition of peanuts has become increasingly important with the realization that oleic acid content significantly affects the development of rancidity. And oil content of peanuts significantly affects flavor and shelf-life. Early generation screening of breeding lines for high oleic acid content greatly increases the efficiency of developing new peanut varieties. The objective of this study was to compare the accuracy of methods used to classify individual peanut seed as high oleic or not high oleic. Three hundred and seventy-four (374) seeds, spanning twenty-three (23) genotypes varying in oil composition (i.e. high oleic (H) or normal/not high oleic (NH) inclusive of all four peanut market-types (runner, Spanish, Valencia and Virginia), were individually tested ...
发表评论
阅读全文

Location Optimization of a Coal Power Plant to Balance Costs against Plant’s Emission Exposure

Fuel and its delivery cost comprise the biggest expense in coal power plant operations. Delivery of electricity from generation to consumers requires investment in power lines and transmission grids. Placing a coal power plant or multiple power plants near dense population centers can lower transmission costs. If a coalmine is nearby, transportation costs can also be reduced. However, emissions from coal plants play a key role in worsening health crises in many countries. And coal upon combustion produces CO 2 , SO 2 , NO x , CO, Metallic and Particle Matter (PM10 & PM2.5). The presence of these chemical compounds in the atmosphere in close vicinity to humans, livestock, and agriculture carries detrimental health consequences. The goal of the research was to develop a methodology to minimize the public’s exposure to harmful emissions from coal power plants while maintaining minimal operational costs related to electric distribution losses and coal logistics. The objective was...
发表评论
阅读全文

Evaluation of the Safety and Efficacy of Continuous Use of a Home-Use High-Frequency Facial Treatment Appliance

At present, many home-use beauty devices are available in the market. In particular, many products developed for facial treatment use light, e.g., a flash lamp or a light-emitting diode (LED). In this study, the safety of 4 weeks’ continuous use of NEWA TM , a high-frequency facial treatment appliance, every alternate day at home was verified, and its efficacy was evaluated in Japanese individuals with healthy skin aged 30 years or older who complained of sagging of the facial skin.  Transepidermal water loss (TEWL), melanin levels, erythema levels, sebum secretion levels, skin color changes and wrinkle improvement in the facial skin were measured before the appliance began to be used (study baseline), at 2 and 4 weeks after it had begun to be used, and at 2 weeks after completion of the 4-week treatment period (6 weeks from the study baseline). In addition, data obtained by subjective evaluation by the subjects themselves on a visual analog scale (VAS) were also analyzed. Fur...
发表评论
阅读全文